Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;34(3):746-754.
doi: 10.1089/neu.2016.4596. Epub 2016 Oct 26.

High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury

Affiliations

High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury

Angelos Papatheodorou et al. J Neurotrauma. 2017 Feb.

Abstract

Inflammation in traumatic spinal cord injury (SCI) has been proposed to promote damage acutely and oppose functional recovery chronically. However, we do not yet understand the signals that initiate or prolong inflammation in persons with SCI. High-Mobility Group Box 1 (HMGB1) is a potent systemic inflammatory cytokine-or damage-associated molecular pattern molecule (DAMP)-studied in a variety of clinical settings. It is elevated in pre-clinical models of traumatic spinal cord injury (SCI), where it promotes secondary injury, and strategies that block HMGB1 improve functional recovery. To investigate the potential translational relevance of these observations, we measured HMGB1 in plasma from adults with acute (≤ 1 week post-SCI, n = 16) or chronic (≥ 1 year post-SCI, n = 47) SCI. Plasma from uninjured persons (n = 51) served as controls for comparison. In persons with acute SCI, average HMGB1 levels were significantly elevated within 0-3 days post-injury (6.00 ± 1.8 ng/mL, mean ± standard error of the mean [SEM]) or 4-7 (6.26 ± 1.3 ng/mL, mean ± SEM), compared with controls (1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.001 and p ≤ 0.01, respectively). In persons with chronic SCI who were injured for 15 ± 1.5 years (mean ± SEM), HMGB1 also was significantly elevated, compared with uninjured persons (3.7 ± 0.69 vs. 1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.0001). Together, these data suggest that HMGB1 may be a common, early, and persistent danger signal promoting inflammation in individuals with SCI.

Keywords: damage-associated molecular pattern; high mobility group box 1; inflammation; spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

For Angelos Papatheodorou, Katie Gibbs, Cristina Sison, Peter Davies and Matthew Bank, no competing financial interests exist.

For Ona Bloom, no competing financial interests exist; however, she received grants from the Craig H. Neilsen Foundation and the New York State Empire Clinical Research Investigator Program, and her institution received a grant from National Center for Research Resources during the conduct of the study. Dr. Bloom received an honorarium from the Craig H. Neilsen Foundation for membership on a peer review panel, outside the submitted work.

For Adam Stein, no competing financial interests exist; however, he reports personal fees from the Craig H. Neilsen Foundation, Stem Cells Inc., and In Vivo Therapeutics outside the submitted work. No compensation is associated with his board membership in the following organizations: Association of Academic Physiatrists and American Spinal Injury Association.

Figures

<b>FIG. 1.</b>
FIG. 1.
High-Mobility Group Box 1 (HMGB1) levels are elevated in persons with acute spinal cord injury (SCI). In all panels, gray dotted bar indicates HMGB1 value obtained from uninjured persons (n = 51). (A) Black bars indicate HMGB1 values obtained at the day post-injury (DPI) indicated. (B) Black bars indicate peak HMGB1 values obtained within 0–3 or 4–6 DPI. (C) Black bars indicate peak HMGB1 values obtained from persons with neurologically complete or incomplete injuries. (D) Black bars indicate peak HMGB1 values obtained from persons with injuries at levels T5 and above or T6 and below. Bars indicate values of participants from indicated group (mean ± standard error of the mean). Numbers over each bar indicate the number of participants from whom the data was obtained. Asterisks indicate statistical significance: ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05 with respect to uninjured group.
<b>FIG. 2.</b>
FIG. 2.
High-Mobility Group Box 1 (HMGB1) levels are elevated in persons with chronic spinal cord injury (SCI). In all panels, gray hatched bar indicates mean HMGB1 value obtained from uninjured persons (n = 51). (A) Black bars indicate HMGB1 values obtained from persons with chronic SCI. (B) Black bars indicate HMGB1 values obtained from persons living with SCI for less or more than 5 years. (C) Black bars indicate HMGB1 values obtained from persons with injuries according to their American Spinal Injury Association Impairment Scale (AIS) grade. (D) Black bars indicate HMGB1 values obtained from persons with injuries at levels T5 and above or T6 and below. Bars indicate values of participants from indicated group (mean ± standard error of the mean). Numbers over each bar indicate the number of participants from whom the data was obtained. Asterisks indicate statistical significance: ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05 with respect to uninjured group. YPI, years post-injury.

References

    1. National Spinal Cord Injury Statistical Center. (2016). Spinal Cord Injury (SCI) Facts and Figures at a Glance. University of Alabama: Birmingham
    1. Schwab J.M., Zhang Y., Kopp M.A., Brommer B., and Popovich P.G. (2014). The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp. Neurol. 258, 121–129 - PMC - PubMed
    1. Kwon B.K., Stammers A.M., Belanger L.M., Bernardo A., Chan D., Bishop C.M., Slobogean G.P., Zhang H., Umedaly H., Giffin M., Street J., Boyd M.C., Paquette S.J., Fisher C.G., and Dvorak M.F. (2010). Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma 27, 669–682 - PubMed
    1. Kwon B.K., Casha S., Hurlbert R.J., and Yong V.W. (2011). Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin. Chem. Lab. Med. 49, 425–433 - PubMed
    1. Pouw M.H., Kwon B.K., Verbeek M.M., Vos P.E., van Kampen A., Fisher C.G., Street J., Paquette S.J., Dvorak M.F., Boyd M.C., Hosman A.J., and van de Meent H. (2014). Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects. Spinal Cord 52, 428–433 - PubMed

Publication types

LinkOut - more resources